Keryx Biopharmaceuticals (KERX)

Add to Watchlists
Create an Alert
7.98 +0.23  +2.97% NASDAQ Jul 31, 20:00 Delayed 2m USD
View Full Chart
KERX Price Chart
View All Events

KERX Events

Date Type Description
06/16/2015 Misc Annual General Meeting for Keryx Biopharmaceuticals Inc
05/04/2015 08:00 EDT Misc Keryx Biopharmaceuticals Inc First Quarter Earnings Conference Call in 2015
05/04/2015 Earnings Keryx Biopharmaceuticals Inc First Quarter Earnings in 2015 Release
02/27/2015 08:00 EST Misc Keryx Biopharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2014
02/27/2015 Earnings Keryx Biopharmaceuticals Inc Fourth Quarter Earnings in 2014 Release
11/06/2014 08:00 EST Misc Q3 2014 Keryx Biopharmaceuticals, Inc. Earnings Conference Call
11/06/2014 Earnings Q3 2014 Keryx Biopharmaceuticals, Inc. Earnings Results
08/07/2014 08:00 EDT Misc Keryx Biopharmaceuticals Inc Q2 2014 Earnings Conference Call
08/07/2014 Earnings Keryx Biopharmaceuticals Inc Q1 2014 Earnings Results
View All Performance Charts

KERX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Keryx Biopharmaceuticals is down 46.98% over the last year vs S&P 500 Total Return up 11.21%, ISIS Pharmaceuticals up 77.25%, and Array BioPharma up 45.25%.

Advertisement

KERX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.keryx.com
  • IR Website: http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-IRHome
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Keryx Biopharmaceuticals Inc is a biopharmaceutical company focused on therapies for patients with renal disease. Its first product is the AuryxiaTM (ferric citrate), an oral, absorbable iron-based compound.

KERX Excel Add-In Codes

  • Name: =YCI("KERX","name")
  • Description: =YCI("KERX","description")
  • Sector: =YCI("KERX","sector")
  • Industry: =YCI("KERX","industry")
  • Est. Current Fiscal Year End: =YCI("KERX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.